[Skip to Navigation]
Comment & Response
August 13, 2020

Targeted Intraoperative Radiotherapy for Early Breast Cancer

Author Affiliations
  • 1Landeskrankenhaus, Hospital Salzburg, Department of Radiotherapy and Radio-Oncology, Paracelsus Medical University, Salzburg, Austria
  • 2Department of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milano, Italy
  • 3Iridium Kankernetwerk, University of Antwerp, Wilrijk-Antwerp, Belgium
JAMA Oncol. 2020;6(10):1636-1637. doi:10.1001/jamaoncol.2020.2719

To the Editor We read with interest the article from Vaidya et al1 on the 5-year outcomes after delayed second-procedure targeted intraoperative radiotherapy (IORT). Unfortunately, the term IORT is often used in a too generalized way, making it prone to confuse the reader in discriminating 50-kV endocavitary x-rays, like in the TARGIT-A trial, from intraoperatively delivered electron radiotherapy (IOERT).

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words